Ardelyx Appoints Korner CMO
This article was originally published in Scrip
Ardelyx, Inc., a company focused on gastrointestinal and cardio-renal disease, has appointed Paul Korner to the newly created position of executive vice president and chief medical officer. Most recently Korner was president, Ferring International Pharmascience Center U.S Inc., and senior vice president, US clinical development for Ferring Pharmaceuticals. Prior to this, Korner was vice president of medical affairs, female health at Bayer Healthcare Pharmaceuticals.